Tissue sample collections and digital services with deep learning -based image analysis solutions now available as a combined service

Helsinki Biobank and medical AI software company Fimmic announce a collaboration by presenting a unique one access service concept. The new service combines Helsinki Biobank´s large collection of pathology samples and world-class digital services with state-of-the art deep learning AI -based image analysis solutions from Fimmic.

Finnish industry organisations in the Life Science field have collaboratively created an internet based mentoring service for start-up companies, fledgling entrepreneurs and researchers interested in commercialising their inventions. The purpose of the service is to share the knowledge of experienced people with beginners and support their business development. The service is offered free of charge.

Faron Pharmaceuticals Oy ("Faron”), the clinical stage biopharmaceutical company, is pleased to announce the commencement of dealings in its Ordinary Shares on the AIM market of the London Stock Exchange with effect from 8.00 a.m. today under the ticker FARN and the ISIN number FI4000153309. This follows a successful placing and subscription for 3,846,154 new Ordinary Shares, raising £10.0 million at a price of 260p per ordinary share (the “Fundraising”).